TORONTO, ONTARIO--(Marketwired - Jun 17, 2015) - Abba Medix Group Inc. (CSE:ABA),is pleased to announce it has engaged Jacob Securities Inc. ("JSI") in relation to proposed strategic and advisory services. In addition to being an advanced stage MMPR applicant, Abba is in the final stages of closing the acquisition of RedeCan Pharm, a fully licensed MMPR producer.
JSI is appointed as the exclusive agent in connection with strategic and operational development of the Abba platform, after market support and future capital raising efforts on a best efforts basis.
"We are pleased to be working with Abba as their strategic advisor and to support the Company in meeting all of its current and future requirements." stated Mr. Sasha Jacob, CEO of JSI.
"We strongly believe Abba is well positioned to become a marketplace leader through its strategy of partnerships and acquisitions tactically aimed towards a fully-integrated, Canadian medical marijuana marketplace."
About Jacob Securities
Jacob Securities is Canada's leading independent investment dealer focused on renewable energy, clean technology and the medical marijuana sector. Based in Toronto, JSI has completed more transactions in the renewable energy and medical marijuana sectors than any other investment dealer in Canada. JSI has participated in transactions valued in excess of $7 billion for renewable power projects since 2006 and raised over $70 million for public and private cannabis companies since 2014. For more information please visit www.jacobsecurities.com.
About Abba Medix Group
Abba Medix Group Inc. (CSE:ABA) is a purveyor of fine Canadian medical marijuana, accessories, events, and news. The Company is becoming a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully-integrated, Canadian medical marijuana marketplace. Abba's mission is to find and acquire strong marijuana related businesses, product companies, organizational event sponsorships, and research and development opportunities.
Through the pending acquisition of RedeCan, Abba is a licensed medical marijuana grower and sales agent, authorized to supply Canadian patients.
For more information on the Abba Medix Group, please visit www.abbamedix.com. To shop RedeCan's medical marijuana strains, visit http://redecanpharm.ca. To shop for the perfect vape at Blow Vapor, visit www.blowvapor.com.
Cautionary Statements Regarding Forward-Looking Information
Certain statements within this press release relating to the Company constitute "forward-looking statements", within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and / or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are "forward-looking statements". Such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and / or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and / or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company's historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.